Another significant endogenous mechanism is the activity of various oxidase enzymes
dark/black), frequency, amount, and any associated symptoms like pain, nausea, or dizziness
D.BrandC
During this exclusivity period, no generic manufacturers can legally produce equivalent versions in the United States
In a post on X, Hims & Hers' chief executive, Andrew Dudum, said that the company will "continue to offer access to personalised treatments as allowed by law to meet patient needs," and will be "closely monitoring" the semaglutide supply chain, given that Novo Nordisk "stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications'." For its part, the FDA said it "has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved." The agency will continue to allow compounders to provide semaglutide to patients on a temporary basis "to avoid unnecessary disruption to patient treatment." State-licensed pharmacy or physician compounders can continue to do so until 22nd April, while outsourcing facilities have a deadline of 22nd May
1 Researchers from Highmark Health and Allegheny Health Network compared the effectiveness of GLP-1 drugs versus bariatric surgery
